Literature DB >> 26108690

MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia.

D C de Leeuw1, H J M P Verhagen1, F Denkers1, F G Kavelaars2, P J M Valk2, G J Schuurhuis1, G J Ossenkoppele1, L Smit1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26108690     DOI： 10.1038/leu.2015.160

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.

Authors:  Elzbieta Gocek; Xuening Wang; Xiuping Liu; Chang-Gong Liu; George P Studzinski
Journal:  Cancer Res       Date:  2011-08-04       Impact factor: 12.701

3.  Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients.

Authors:  Guido Marcucci; Kati S Maharry; Klaus H Metzeler; Stefano Volinia; Yue-Zhong Wu; Krzysztof Mrózek; Deedra Nicolet; Jessica Kohlschmidt; Susan P Whitman; Jason H Mendler; Sebastian Schwind; Heiko Becker; Ann-Kathrin Eisfeld; Andrew J Carroll; Bayard L Powell; Jonathan E Kolitz; Ramiro Garzon; Michael A Caligiuri; Richard M Stone; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

4.  Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.

Authors:  Fernando P G Silva; Sigrid M A Swagemakers; Claudia Erpelinck-Verschueren; Bas J Wouters; Ruud Delwel; Harry Vrieling; Peter van der Spek; Peter J M Valk; Micheline Giphart-Gassler
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

5.  MicroRNA miR-125b causes leukemia.

Authors:  Marina Bousquet; Marian H Harris; Beiyan Zhou; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

6.  Stem cell gene expression programs influence clinical outcome in human leukemia.

Authors:  Kolja Eppert; Katsuto Takenaka; Eric R Lechman; Levi Waldron; Björn Nilsson; Peter van Galen; Klaus H Metzeler; Armando Poeppl; Vicki Ling; Joseph Beyene; Angelo J Canty; Jayne S Danska; Stefan K Bohlander; Christian Buske; Mark D Minden; Todd R Golub; Igor Jurisica; Benjamin L Ebert; John E Dick
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

7.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

8.  microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.

Authors:  Yoon-Chi Han; Christopher Y Park; Govind Bhagat; Jinping Zhang; Yulei Wang; Jian-Bing Fan; Mofang Liu; Yongrui Zou; Irving L Weissman; Hua Gu
Journal:  J Exp Med       Date:  2010-03-08       Impact factor: 14.307

9.  MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia.

Authors:  N Feller; M A van der Pol; A van Stijn; G W D Weijers; A H Westra; B W Evertse; G J Ossenkoppele; G J Schuurhuis
Journal:  Leukemia       Date:  2004-08       Impact factor: 11.528

10.  Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.

Authors:  David C de Leeuw; Fedor Denkers; Marjolein C Olthof; Arjo P Rutten; Walter Pouwels; Gerrit Jan Schuurhuis; Gert J Ossenkoppele; Linda Smit
Journal:  Cancer Res       Date:  2014-01-29       Impact factor: 12.701
View more
  13 in total

Review 1.  MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.

Authors:  Jared A Wallace; Ryan M O'Connell
Journal:  Blood       Date:  2017-07-27       Impact factor: 22.113

Review 2.  MicroRNAs as prognostic biomarker and relapse indicator in leukemia.

Authors:  S Hajizamani; M Shahjahani; S Shahrabi; N Saki
Journal:  Clin Transl Oncol       Date:  2017-03-07       Impact factor: 3.405

3.  Widespread use of measurable residual disease in acute myeloid leukemia practice.

Authors:  Zachary D Epstein-Peterson; Sean M Devlin; Eytan M Stein; Elihu Estey; Martin S Tallman
Journal:  Leuk Res       Date:  2018-02-13       Impact factor: 3.156

4.  A plasmonic colorimetric strategy for visual miRNA detection based on hybridization chain reaction.

Authors:  Jie Miao; Jingsheng Wang; Jinyang Guo; Huiguang Gao; Kun Han; Chengmin Jiang; Peng Miao
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

Review 5.  Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?

Authors:  Tania Martiáñez Canales; David C de Leeuw; Eline Vermue; Gert J Ossenkoppele; Linda Smit
Journal:  Cancers (Basel)       Date:  2017-06-30       Impact factor: 6.639

6.  miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.

Authors:  Yanping Liu; Wei Hong; Cancan Zhou; Zhengdong Jiang; Guanghui Wang; Guangbing Wei; Xuqi Li
Journal:  Oncol Rep       Date:  2017-04-03       Impact factor: 3.906

Review 7.  MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.

Authors:  Stefania Trino; Daniela Lamorte; Antonella Caivano; Ilaria Laurenzana; Daniela Tagliaferri; Geppino Falco; Luigi Del Vecchio; Pellegrino Musto; Luciana De Luca
Journal:  Int J Mol Sci       Date:  2018-02-03       Impact factor: 5.923

8.  MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia.

Authors:  Mingshan Niu; Ninghan Zhang; Rong Wang; Tingting Shao; Yuan Feng; Yangling Shen; Xuejiao Liu; Kai Zhao; Shengyun Zhu; Linyan Xu; Yao Yao; Kailin Xu
Journal:  Front Oncol       Date:  2019-10-11       Impact factor: 6.244

9.  NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.

Authors:  Yu-Qiong Yang; Tian Tian; Hua-Yuan Zhu; Jin-Hua Liang; Wei Wu; Jia-Zhu Wu; Yi Xia; Li Wang; Lei Fan; Jian-Yong Li; Wei Xu
Journal:  BMC Cancer       Date:  2018-10-22       Impact factor: 4.430

10.  MicroRNA-181a-3p as a Diagnostic and Prognostic Biomarker for Acute Myeloid Leukemia.

Authors:  Ping Qiang; Qing Pan; Chao Fang; Claudio Fozza; Kaidi Song; Yuanyuan Dai; Wenjiao Chang; Wei Chen; Wan Yao; Weibo Zhu; Xin Liu; Xiaoling Ma
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-03-01       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.